HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$2.10
Day range
$2.11 - $2.21
Year range
$1.01 - $3.95
Market cap
150.02M USD
Avg Volume
652.06K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 38.59M | -47.12% |
Net income | -35.22M | 25.82% |
Net profit margin | — | — |
Earnings per share | -0.49 | 20.17% |
EBITDA | -38.44M | 16.07% |
Effective tax rate | -1.27% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 245.89M | -33.74% |
Total assets | 288.97M | -32.85% |
Total liabilities | 72.76M | -21.89% |
Total equity | 216.20M | — |
Shares outstanding | 70.93M | — |
Price to book | 0.67 | — |
Return on assets | -31.31% | — |
Return on capital | -35.39% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -35.22M | 25.82% |
Cash from operations | -30.94M | 22.07% |
Cash from investing | 32.45M | 0.51% |
Cash from financing | -4.59M | — |
Net change in cash | -3.08M | 58.53% |
Free cash flow | -38.12M | -590.57% |
About
Founded
2014
Website
Employees
106
